Sycai Technologies — Series A · €3M

Sycai Medical (Sycai Technologies) raised €3M from a pan-European consortium co-led by Dutch fund LUMO Labs and Barcelona's Ship2B Ventures (via its BSocial Impact Fund), with Athos Capital and Namarel Ventures also participating; Crunchbase files the round as a Series A while Spanish press reported it simply as a €3M round. Proceeds fund the European commercial launch of its MDR CE-marked pancreatic application (obtained summer 2024), extension of the product to liver and kidney lesions, and US clinical validation toward FDA clearance.